Stoma/Ostomy Care Market Booming Trends, Growth and Forecast 2023 to 2033

The global Stoma/Ostomy Care Market size is estimated to reach US$ 3.8 billion by the end of 2022, and to increase at a compound annual growth rate (CAGR) of 4.9% between 2023 and 2033, reaching a market value of nearly US$ 6.5 billion by 2033. The increasing prevalence of diseases needing ostomy care, innovations in surgical procedures and ostomy supplies, increased awareness, and reimbursements all contribute to the expansion of the stoma care industry.

Colorectal cancer, bladder cancer, and inflammatory bowel disease are the most common disorders needing ostomy care, and are treated by surgical excision of malignant melanoma of the intestine (IBD). An ostomy, which includes making a surgical incision through the belly to build a new waste minimization channel, is required in some circumstances.

Because of the increasing prevalence of these diseases and greater exposure to risk factors such as altered dietary habits and increased antibiotic use in children, the adoption of Stoma/Ostomy Care techniques has expanded worldwide.

Nonetheless, despite recent advances, the stoma/ostomy market is constrained by numerous factors that limit its growth potential. These include stoma care challenges, ostomy product discomfort and other concerns, societal stigma, and greater acceptance of alternative medicines, particularly in poor nations.

While stoma procedures are generally safe, there are certain dangers associated, including potentially fatal complications like as necrosis and fatigue. As a result, stoma care appliance acceptability may be limited to some extent.

Key players in the Stoma/Ostomy Care Market

BAE Systems Plc, ConvaTec Inc., Hollister Inc., EuroMed, Inc, 3M Company, Smith & Nephew plc, FNC Medical, Nu–Hope Laboratories, Inc., Marlen Manufacturing & Development Co., Torbot Group, Inc, Cymed Micro Skin, Alcare Co., Ltd., B. Braun Melsungen AG., Salts Healthcare Ltd, Securi–T USA., Welland Medical Limited, Flexicare Group Limited.

Browse Detail Summary@ https://www.futuremarketinsights.com/reports/stoma-ostomy-care-market

Key Segments

By Surgery Type:

  • Colostomy
  • Ileostomy
  • Urostomy

By Product:

  • Ostomy Bags
  • Ostomy Accessories
    • Belts & Tapes
    • Skin Protection &Skin Barrier
    • Irrigation Sets
    • Convex Inserts
    • Stoma Caps

By Application:

  • Cancer
  • Inflammatory Bowel Disease
  • Bowel Obstruction
  • Fecal Incontinence
  • Trauma and Infection

By End–Users:

  • Hospitals and Specialty Clinics
  • Home Care Settings
  • Ambulatory Surgical Centers

Comments

Post a Comment

Popular posts from this blog

Handheld Ultrasound Scanners Market Will Generate Booming Growth Opportunities to 2032

Image
According to industry predictions, the global Handheld Ultrasound Scanners Market Demand will increase at a CAGR of 9.1% from 2022 to 2032, reaching a value of US$ 472.1 million by the end of 2022. By 2032, sales are estimated to exceed a valuation of roughly US$ 1.1 billion. With an expected 83.6% market share in 2021, the wired modality now leads the sector. Because they connect to Bluetooth or Wi-Fi devices such as mobile phones or tablets, Handheld Ultrasound Scanners are gaining appeal among both medical professionals and non-radiologists. These devices improve networking systems and ease picture transfer to medical facilities. Global Handheld Ultrasound Scanners Market: Dynamics         Technological advancements in medical imaging devices, increased use of Handheld Ultrasound Scanners among non-radiologists, benefits from international trade agreements, increased importing of imaging diagnostics systems, increased use of Handheld Ultrasound Scanners in emergency medical service
Read more

Targeted Therapies for Sandhoff Disease | Assessing the Global Market Landscape

Image
The global Sandhoff Disease Therapeutics Market Size is expected to be worth US$ 10 million in 2023 and US$ 17.91 million by 2033, with a CAGR of 6% from 2023 to 2033. From 2018 to 2022, the Sandhoff Disease Treatments market increased at a 4% CAGR. According to the most recent studies, Sandhoff sickness is a rare disorder that affects 1 in 1,000,000 people. The rising demand for these medications is projected to spur the discovery of novel therapies, propelling the market forward in the coming years. Gene therapy is being investigated as a potential treatment for Sandhoff disease. The therapy restores the ability to break down GM2 ganglioside by delivering a functional copy of the missing enzyme into the patient's cells. This has the potential to reduce or stop disease progression while also improving patient quality of life. Key Takeaways from the Market Study   The Sandhoff Disease Therapeutics market increased at a 4% CAGR from 2018 to 2022. From 2023 to 2033, the global Sandh
Read more

Antidiabetics Market to reach US$ 223 billion by 2032, growing at a 9.6% CAGR from 2022 to 2032 | Future Market Insights, Inc.

Image
The global Antidiabetics Market is expected to earn US$ 223 billion while expanding at a CAGR of 9.6% during the forecast period. The rising prevalence of diabetes worldwide can be attributed to the market's expansion. The ageing baby boomer population is another factor driving the market during the forecast period. According to the International Diabetes Federation, the global diabetes incidence will increase from 366 million in 2011 to 552 million by 2030. During the forecast period, the industry is expected to benefit from a significant increase in the number of diabetic patients. Furthermore, new product development is expected to benefit the market in the near future. For example, Novo Nordisk, a Danish pharmaceutical company, announced the launch of oral semaglutide for the treatment of Type 2 diabetes in India in January 2022. Furthermore, the development of advanced pumps based on smart technologies like AI and ML is expected to open up a slew of new doors. For exampl
Read more